Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Cerevel Therapeutics Holdings Inc
About CERE
Cerevel Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on neuroscience that combines an understanding of disease-related biology and neurocircuitry of the brain with advanced chemistry and central nervous system (CNS) target receptor selective pharmacology to discover and design new therapies. It focuses on transform the lives of patients through the development of new therapies for neuroscience diseases, including schizophrenia, Alzheimer’s disease psychosis, epilepsy, panic disorder and Parkinson’s disease. Its pipeline candidates include Emraclidine, Darigabat, Tavapadon and CVL-871. Emraclidine is a positive allosteric modulator (PAM), that selectively targets the muscarinic acetylcholine 4 receptor subtype (M4). Darigabat is a PAM that selectively targets the alpha 2/3/5 subunits of the GABAA receptor. Tavapadon is a selective dopamine D1/D5 receptor partial agonist that it is developing for the treatment of Parkinson’s disease.
Find out what a historical investment in Cerevel Therapeutics Holdings Inc would be worth today using our CERE stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy CERE shares in Australia?
Buying CERE shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Cerevel Therapeutics Holdings Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in CERE
What is the ticker symbol of Cerevel Therapeutics Holdings Inc?
The ticker symbol for Cerevel Therapeutics Holdings Inc is CERE.
How much is one share of CERE?
One share of CERE is valued at $44.96 as of 17 May 2026.
What is the market capitalisation of Cerevel Therapeutics Holdings Inc CERE?
As of 17 May 2026 Cerevel Therapeutics Holdings Inc has a market cap of -.
What is the 52-week high for Cerevel Therapeutics Holdings Inc stock?
The Cerevel Therapeutics Holdings Inc 52-week high stock price is $NaN.
What is the 52-week low for Cerevel Therapeutics Holdings Inc stock?
The Cerevel Therapeutics Holdings Inc 52-week low stock price is $NaN.
Can I buy CERE shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy CERE shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CERE on Stake
- Buy CERE from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of CERE from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
CERE related stocks